Anthropic has announced that its AI system, Claude, has independently identified a novel enzyme system with potential applications similar to the gene-editing technology CRISPR. The discovery represents the initial output from the company’s newly established wet laboratory and serves as an early demonstration of Claude’s capability to contribute to scientific research. This development comes as Anthropic prepares for its upcoming public offering.
According to the company, Claude located the enzyme system by analyzing a vast repository of DNA sequences. Anthropic noted that human scientists limited their involvement to providing the initial prompt and conducting the subsequent laboratory work. Over a period of 21 hours, approximately 950 instances of Claude processed 210 million tokens before identifying an unusual repeating pattern within the data.
Hold on—is this really comparable to CRISPR, or is the marketing overstating the similarity? Let’s see peer review first.
Twenty-one hours versus years for humans. That’s not just an improvement; it’s a completely different scale of innovation.
This changes everything for biotech research timelines. We might be seeing the dawn of AI-native laboratories very soon.
Is this genuinely autonomous, or were human scientists subtly guiding the results? Skeptical about the ‘independent’ claim here.
Fascinating that Claude did the heavy lifting in just twenty-one hours. The speed of AI-driven discovery is truly breathtaking.